For funds
Your book, run the way this room runs the FDA calendar
The room at kxco.ai/fda reads every filing on its board from the sponsors' own words: the decision dates, the FDA's letters, the trials, the people and the market around each one. Every fact carries the address it came from and the words it was read from. We build the same room on the names you hold.
Run by people whose backgrounds are BlackRock, Fidelity, DTCC, Bear Stearns, Capgemini and the Knightsbridge Group.
A record of every name, built from what was actually said
- Every regulatory clock on your names, each date quoted from the company's own release or SEC filing, and marked where a date could not be re-read rather than filled in.
- The regulator's own letters set beside what the company told the market, with the days between them.
- The trials, the registrations behind them, and the directors and officers named in each company's own SEC filings.
- What the market already prices beside what the record holds: the options-implied move into each decision, cash and runway, and insider trades over 90 days.
- A watch that re-reads the status of every filing twice a day and tells you when a headline says something changed, so a withdrawal never sits on your board as a coming decision.
- Calls fixed and signed before each decision and scored when it lands, kept for your own record or published, as you decide.
A fact without its source does not reach the page
The FDA room holds 567 claims across 548 entities and 703 sources, as at 2026-11-16, per kxco.ai/fda. Every build runs checks that refuse to publish a quote not on its page word for word. They also refuse a decision date that has passed with no record of what happened, and a call shown before it was meant to be. Each check is proved by planting the fault it exists to catch and confirming it refuses.
Where we tested something and it did not hold, we said so and did not publish it. The room tested a probability of approval for each filing before publishing one. It did not reliably beat the base rate on years it had not seen, so the room publishes no modelled probability of approval for any one filing; the first screen uses each call's first-cycle approval rate counted across every application, refused ones included.
The questions your room answers
A room built for your book puts these questions to its record and answers each one with the claims behind it. Where the record cannot answer a question yet, the room says so and names what would close it.
- Which filings have an FDA goal date in the next 90 days, and is each on a priority or a standard review?
- Has the FDA refused this drug before, and on what grounds, in its own letter?
- For each biologic, who makes it, and has a manufacturing or facility finding grounded a refusal?
- Which trials support each filing, and does the registry agree with the sponsor?
- Which officers or directors were insiders at a company that took another drug to approval?
- Which conditions carry more than one filing?
- Has the FDA given notice of an advisory committee for any pending filing?
- Who owns each drug today, and since when?
- Was a withdrawn filing ever decided? The room must answer no, from the withdrawal itself.
6 days from a first screen to a live room
The FDA room went from a first screen on 17 September 2026 to a live room on 23 September 2026. It has been extended and corrected in public since, and its record of what changed is on the page.
Start with 5 names you hold
Send up to five names from your book. We build their board, sourced the same way, before you decide anything. We quote on your list.